RESIDUAL CANCER BURDEN Trademark

Trademark Overview


On Thursday, January 6, 2022, a trademark application was filed for RESIDUAL CANCER BURDEN with the United States Patent and Trademark Office. The USPTO has given the RESIDUAL CANCER BURDEN trademark a serial number of 97205532. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, October 2, 2023. This trademark is owned by Delphi Diagnostics, Inc.. The RESIDUAL CANCER BURDEN trademark is filed in the Medical Instrument Products, Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:

Providing a website via a global computer network featuring a residual cancer burden calculator

Medical testing, prediction and assessment for diagnostic, prognosis and treatment purposes in the field of cancer research and disease classification; Providing medical, assessment and prediction information to medical professionals in the field of cancer and disease classification; Providing medical information, assessment and prediction to medical professionals on sensitivities of cancers to hormones and/or hormone therapies

Medical diagnostic apparatus for assessing and predicting recurrence of cancer cells incorporating recorded operating system software

Medical and scientific research in the field of assessing and predicting recurrence cancer after treatment and diagnosis; Medical research services in the field of assessing and predicting recurrence of cancer; Providing laboratory research services in the field of assessing and predicting effectiveness of treatment and diagnosis in gene expression, namely, cancer biology; Research and development of pharmaceuticals for the assessment and prediction of effectiveness of treatment of age-related diseases and cancer; Assessment and predictions of medical diagnosis and treatment of cancer; Providing information about medical research, predictions and assessments in the field of cancer
residual cancer burden

General Information


Serial Number97205532
Word MarkRESIDUAL CANCER BURDEN
Filing DateThursday, January 6, 2022
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateMonday, October 2, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesProviding a website via a global computer network featuring a residual cancer burden calculator
Goods and ServicesMedical testing, prediction and assessment for diagnostic, prognosis and treatment purposes in the field of cancer research and disease classification; Providing medical, assessment and prediction information to medical professionals in the field of cancer and disease classification; Providing medical information, assessment and prediction to medical professionals on sensitivities of cancers to hormones and/or hormone therapies
Goods and ServicesMedical diagnostic apparatus for assessing and predicting recurrence of cancer cells incorporating recorded operating system software
Goods and ServicesMedical and scientific research in the field of assessing and predicting recurrence cancer after treatment and diagnosis; Medical research services in the field of assessing and predicting recurrence of cancer; Providing laboratory research services in the field of assessing and predicting effectiveness of treatment and diagnosis in gene expression, namely, cancer biology; Research and development of pharmaceuticals for the assessment and prediction of effectiveness of treatment of age-related diseases and cancer; Assessment and predictions of medical diagnosis and treatment of cancer; Providing information about medical research, predictions and assessments in the field of cancer

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, February 22, 2023
Primary Code010
First Use Anywhere DateMonday, October 1, 2007
First Use In Commerce DateMonday, October 1, 2007

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code042
First Use Anywhere DateMonday, October 1, 2007
First Use In Commerce DateMonday, October 1, 2007

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code044
First Use Anywhere DateMonday, October 1, 2007
First Use In Commerce DateMonday, October 1, 2007

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, January 10, 2022
Primary Code045
First Use Anywhere DateMonday, October 1, 2007
First Use In Commerce DateMonday, October 1, 2007

Trademark Owner History


Party NameDelphi Diagnostics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77055

Trademark Events


Event DateEvent Description
Monday, October 2, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Monday, October 2, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, October 2, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, May 25, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 25, 2023NON-FINAL ACTION E-MAILED
Thursday, May 25, 2023NON-FINAL ACTION WRITTEN
Thursday, April 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 26, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 27, 2023AMENDMENT TO USE PROCESSING COMPLETE
Thursday, April 27, 2023USE AMENDMENT FILED
Wednesday, April 26, 2023TEAS AMENDMENT OF USE RECEIVED
Wednesday, March 8, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 8, 2023NON-FINAL ACTION E-MAILED
Wednesday, March 8, 2023NON-FINAL ACTION WRITTEN
Tuesday, February 14, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 14, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, February 14, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, January 31, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 31, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 31, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 15, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, August 15, 2022NON-FINAL ACTION E-MAILED
Monday, August 15, 2022NON-FINAL ACTION WRITTEN
Wednesday, July 20, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 20, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 20, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 23, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 23, 2022NON-FINAL ACTION E-MAILED
Monday, May 23, 2022NON-FINAL ACTION WRITTEN
Tuesday, May 3, 2022ASSIGNED TO EXAMINER
Monday, January 10, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 10, 2022NEW APPLICATION ENTERED